chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 71.0
Sex: F
Vaccine: COVID19
Symptoms: Colonoscopy, Dry eye, Endoscopy, Gastrooesophageal reflux disease, Irritable bowel syndrome
Clinical narrative: Irritable bowel syndrome; Dry eyes; occular migraines; reflux severe; This spontaneous case was reported by a consumer and describes the occurrence of DRY EYE (Dry eyes), RETINAL MIGRAINE (occular migraines), GASTROOESOPHAGEAL REFLUX DISEASE (reflux severe) and IRRITABLE BOWEL SYNDROME (Irritable bowel syndrome) in a 71-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 024M20A and 011L20A) for COVID-19 vaccination.     Concurrent medical conditions included Hashimoto's disease since June 2007, Raynaud's syndrome, Migraine since 07-Jan-2021, Drug allergy, Drug allergy and Drug allergy. Concomitant products included THYROID (ARMOUR THYROID) for Hashimoto's thyroiditis, ACEBUTOLOL for Premature ventricular contractions, AMLODIPINE for Premature ventricular contractions, Raynaud's syndrome and Blood pressure, CALCIUM LACTATE, CALCIUM PHOSPHATE, COLECALCIFEROL (CALCIUM & VITAMIN D [CALCIUM LACTATE;CALCIUM PHOSPHATE;COLECALCIFEROL]) and ASCORBIC ACID, ZINC CITRATE (ZINC + VITAMIN C) for an unknown indication.   On 18-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 15-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. In January 2021, the patient experienced RETINAL MIGRAINE (occular migraines) and GASTROOESOPHAGEAL REFLUX DISEASE (reflux severe). In February 2021, the patient experienced DRY EYE (Dry eyes). On an unknown date, the patient experienced IRRITABLE BOWEL SYNDROME (Irritable bowel syndrome). The patient was treated with FAMOTIDINE (PEPCID AC) at a dose of 40 mg. At the time of the report, DRY EYE (Dry eyes), RETINAL MIGRAINE (occular migraines), GASTROOESOPHAGEAL REFLUX DISEASE (reflux severe) and IRRITABLE BOWEL SYNDROME (Irritable bowel syndrome) had not resolved. Not Provided    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Colonoscopy: normal (normal) normal. On an unknown date, Endoscopy: normal (normal) normal.         Most recent FOLLOW-UP information incorporated above includes: On 21-Jul-2021: Follow up information received contains added events: irritable bowl syndrome, dizziness, stomach pain, reflux severe and added concomitant and treatment medication. Lab tests: Colonoscopy, endoscopy, CT scan and high resolution manometry test are  added
Age: 71.0
Sex: F
Vaccine: COVID19
Symptoms: Retinal migraine
Clinical narrative: Irritable bowel syndrome; Dry eyes; occular migraines; reflux severe; This spontaneous case was reported by a consumer and describes the occurrence of DRY EYE (Dry eyes), RETINAL MIGRAINE (occular migraines), GASTROOESOPHAGEAL REFLUX DISEASE (reflux severe) and IRRITABLE BOWEL SYNDROME (Irritable bowel syndrome) in a 71-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 024M20A and 011L20A) for COVID-19 vaccination.     Concurrent medical conditions included Hashimoto's disease since June 2007, Raynaud's syndrome, Migraine since 07-Jan-2021, Drug allergy, Drug allergy and Drug allergy. Concomitant products included THYROID (ARMOUR THYROID) for Hashimoto's thyroiditis, ACEBUTOLOL for Premature ventricular contractions, AMLODIPINE for Premature ventricular contractions, Raynaud's syndrome and Blood pressure, CALCIUM LACTATE, CALCIUM PHOSPHATE, COLECALCIFEROL (CALCIUM & VITAMIN D [CALCIUM LACTATE;CALCIUM PHOSPHATE;COLECALCIFEROL]) and ASCORBIC ACID, ZINC CITRATE (ZINC + VITAMIN C) for an unknown indication.   On 18-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 15-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. In January 2021, the patient experienced RETINAL MIGRAINE (occular migraines) and GASTROOESOPHAGEAL REFLUX DISEASE (reflux severe). In February 2021, the patient experienced DRY EYE (Dry eyes). On an unknown date, the patient experienced IRRITABLE BOWEL SYNDROME (Irritable bowel syndrome). The patient was treated with FAMOTIDINE (PEPCID AC) at a dose of 40 mg. At the time of the report, DRY EYE (Dry eyes), RETINAL MIGRAINE (occular migraines), GASTROOESOPHAGEAL REFLUX DISEASE (reflux severe) and IRRITABLE BOWEL SYNDROME (Irritable bowel syndrome) had not resolved. Not Provided    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Colonoscopy: normal (normal) normal. On an unknown date, Endoscopy: normal (normal) normal.         Most recent FOLLOW-UP information incorporated above includes: On 21-Jul-2021: Follow up information received contains added events: irritable bowl syndrome, dizziness, stomach pain, reflux severe and added concomitant and treatment medication. Lab tests: Colonoscopy, endoscopy, CT scan and high resolution manometry test are  added
Sex: M
Vaccine: COVID19
Symptoms: COVID-19
Clinical narrative: A spontaneous report was received from a Consumer concerning a patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced events diagnosed of positive covid-19 after getting the first dose of moderna coivd-19 vaccine. The patient's medical history was not provided. No relevant concomitant medications were reported. On 7 Jan 2021, prior to the onset of the events the patient received their first of two planned doses of mRNA-1273 (lot/batch: unknown) intramuscularly for prophylaxis of COVID-19 infection. Diagnosed of positive COVID-19 after getting the first dose of Moderna COIVD-19 vaccine. Action taken with mRNA-1273 in response to the events was not reported. The outcome of event(s), diagnosed of positive covid-19 after getting the first dose of moderna coivd-19 vaccine was unknown.
Age: 73.0
Sex: F
Vaccine: COVID19
Symptoms: Hyperphagia, Pain, Pain in extremity, Pyrexia
Clinical narrative: pain; fever; soreness on her arm; feels hungry more than normal; A spontaneous report was received from a Consumer concerning a 73-years-old female patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced events pain, fever and soreness on her arm, feels hungry more than normal.  The patient's medical history was not provided. Concomitant medications reported were Losartan 25mg for drug use for unknown indication.  On 3 Feb 2021, prior to the onset of the events the patient received their first of two planned doses of mRNA-1273 (lot/batch: 007m20a) intramuscularly for prophylaxis of COVID-19 infection.  On 3 Feb 2021, the patient experienced the events pain. fever and soreness on her arm, feels hungry more than normal.  Treatment details included Ibuprofen 200mg  Action taken with mRNA-1273 in response to the events was not reported.   On an unknown date the outcome of events, pain, On an unknown date the outcome of events, fever and soreness on her arm, On an unknown date the outcome of events, feels hungry more than normal was not reported.
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site pain, Vaccination site pruritus, Vaccination site swelling
Clinical narrative: itching at the injection site; pain at Injection site; redness at the injection site; swelling at the injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PRURITUS (itching at the injection site), VACCINATION SITE PAIN (pain at Injection site), VACCINATION SITE ERYTHEMA (redness at the injection site) and VACCINATION SITE SWELLING (swelling at the injection site) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 27-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 04-Feb-2021, the patient experienced VACCINATION SITE PRURITUS (itching at the injection site), VACCINATION SITE PAIN (pain at Injection site), VACCINATION SITE ERYTHEMA (redness at the injection site) and VACCINATION SITE SWELLING (swelling at the injection site). At the time of the report, VACCINATION SITE PRURITUS (itching at the injection site), VACCINATION SITE PAIN (pain at Injection site), VACCINATION SITE ERYTHEMA (redness at the injection site) and VACCINATION SITE SWELLING (swelling at the injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medication information was provided. No treatment medication information was provided.
Age: 93.0
Sex: M
Vaccine: COVID19
Symptoms: Feeling abnormal, Pyrexia, Vomiting
Clinical narrative: terrible night; fever; vomiting; This spontaneous case was reported by a consumer and describes the occurrence of FEELING ABNORMAL (terrible night), PYREXIA (fever) and VOMITING (vomiting) in a 93-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 23-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 23-Feb-2021, the patient experienced FEELING ABNORMAL (terrible night), PYREXIA (fever) and VOMITING (vomiting). At the time of the report, FEELING ABNORMAL (terrible night) outcome was unknown and PYREXIA (fever) and VOMITING (vomiting) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported. No treatment related information has been reported.
Age: 83.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site pain
Clinical narrative: Pain at injection site; Red area/redness almost gone but she feels it there; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (Pain at injection site) and VACCINATION SITE ERYTHEMA (Red area/redness almost gone but she feels it there) in an 83-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 029K20A) for COVID-19 vaccination.     Concurrent medical conditions included Blood pressure abnormal, High cholesterol and Acid reflux (esophageal).   On 28-Jan-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 29-Jan-2021, the patient experienced VACCINATION SITE PAIN (Pain at injection site) and VACCINATION SITE ERYTHEMA (Red area/redness almost gone but she feels it there). At the time of the report, VACCINATION SITE PAIN (Pain at injection site) outcome was unknown and VACCINATION SITE ERYTHEMA (Red area/redness almost gone but she feels it there) was resolving.            The concomitant medications included blood thinner pills, blood pressure pills, high cholesterol pills, medication for reflux. The patient did not take any treatment for adverse events.
Age: 85.0
Sex: F
Vaccine: COVID19
Symptoms: Fall, Myalgia
Clinical narrative: Tripped over something in house; Extreme pain in back of arm in the muscle; This spontaneous case was reported by a consumer and describes the occurrence of FALL (Tripped over something in house) and MYALGIA (Extreme pain in back of arm in the muscle) in an 85-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 11-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 11-Feb-2021, the patient experienced MYALGIA (Extreme pain in back of arm in the muscle). On an unknown date, the patient experienced FALL (Tripped over something in house). The patient was treated with PARACETAMOL (TYLENOL EXTRA STRENGTH) for Pain, at an unspecified dose and frequency. At the time of the report, FALL (Tripped over something in house) outcome was unknown and MYALGIA (Extreme pain in back of arm in the muscle) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications reported by investigator; Sender's Comments: Very limited information regarding this events has been provided at this time. Further information has been requested. Company assessed the events to be unlikely related to company product.
Age: 92.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site pain
Clinical narrative: soreness when touched; This spontaneous case was reported by a consumer and describes the occurrence of INJECTION SITE PAIN (soreness when touched) in a 92-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 0BM201A and 027L20A) for COVID-19 vaccination.     No Medical History information was reported.   On 06-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 03-Feb-2021, the patient experienced INJECTION SITE PAIN (soreness when touched). At the time of the report, INJECTION SITE PAIN (soreness when touched) had not resolved.            Action taken with mRNA-1273 in response to the drug was not applicable. No concomitant medication information was provided. No treatment medication information was provided. The patient reported soreness when touched (around the injection site) symptom started when given the shot, and symptoms is still going on.
Age: 71.0
Sex: M
Vaccine: COVID19
Symptoms: Body temperature, Chills, Peripheral swelling, Pyrexia, Somnolence
Clinical narrative: Fever 102.5; Chills; Felt like really groggy, drowsy, was really sleepy; Arm  swelling; This spontaneous case was reported by a consumer and describes the occurrence of PERIPHERAL SWELLING (Arm  swelling), SOMNOLENCE (Felt like really groggy, drowsy, was really sleepy), PYREXIA (Fever 102.5) and CHILLS (Chills) in a 71-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 03-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 04-Feb-2021, the patient experienced PERIPHERAL SWELLING (Arm  swelling). On 06-Feb-2021, the patient experienced SOMNOLENCE (Felt like really groggy, drowsy, was really sleepy). On 07-Feb-2021, the patient experienced PYREXIA (Fever 102.5) and CHILLS (Chills). At the time of the report, PERIPHERAL SWELLING (Arm  swelling), SOMNOLENCE (Felt like really groggy, drowsy, was really sleepy), PYREXIA (Fever 102.5) and CHILLS (Chills) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 07-Feb-2021, Body temperature: 102.5 (High) 102.5.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported. No treatment related information has been reported.
Age: 78.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site swelling, Vaccination site warmth
Clinical narrative: Little swelling; Red circle 1 and 3/4 inches down her arm and it was hot to touch; red circle 1 and 3/4 inches down her arm and it was hot to touch; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE WARMTH (red circle 1 and 3/4 inches down her arm and it was hot to touch), VACCINATION SITE SWELLING (Little swelling) and VACCINATION SITE ERYTHEMA (Red circle 1 and 3/4 inches down her arm and it was hot to touch) in a 78-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 26-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-Feb-2021, the patient experienced VACCINATION SITE WARMTH (red circle 1 and 3/4 inches down her arm and it was hot to touch) and VACCINATION SITE ERYTHEMA (Red circle 1 and 3/4 inches down her arm and it was hot to touch). On 05-Feb-2021, the patient experienced VACCINATION SITE SWELLING (Little swelling). On 04-Feb-2021, VACCINATION SITE WARMTH (red circle 1 and 3/4 inches down her arm and it was hot to touch) and VACCINATION SITE ERYTHEMA (Red circle 1 and 3/4 inches down her arm and it was hot to touch) had resolved. At the time of the report, VACCINATION SITE SWELLING (Little swelling) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications reported.  No treatment information was provided.
Sex: U
Vaccine: COVID19
Symptoms: Pruritus, Urticaria
Clinical narrative: itching (itch) (just started 3 or 4 days ago) on back of neck; welted up; This spontaneous case was reported by a consumer and describes the occurrence of PRURITUS (itching (itch) (just started 3 or 4 days ago) on back of neck) and URTICARIA (welted up) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included Surgery (Neck surgery).    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PRURITUS (itching (itch) (just started 3 or 4 days ago) on back of neck) and URTICARIA (welted up). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) at an unspecified dose and frequency. At the time of the report, PRURITUS (itching (itch) (just started 3 or 4 days ago) on back of neck) and URTICARIA (welted up) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications were reported.
Age: 68.0
Sex: F
Vaccine: COVID19
Symptoms: Abdominal pain upper, Diarrhoea
Clinical narrative: diarrhoea; Stomach cramps; This spontaneous case was reported by a consumer and describes the occurrence of DIARRHOEA (diarrhoea) and ABDOMINAL PAIN UPPER (Stomach cramps) in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced DIARRHOEA (diarrhoea) and ABDOMINAL PAIN UPPER (Stomach cramps). At the time of the report, DIARRHOEA (diarrhoea) and ABDOMINAL PAIN UPPER (Stomach cramps) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported. No treatment related information has been reported.
Age: 72.0
Sex: F
Vaccine: COVID19
Symptoms: Erythema, Pain in extremity, Vaccination site warmth
Clinical narrative: days/couple weeks she found a red patch on left arm; Felt a little warm the second day of first dose (left arm); soreness after first dose (left arm); This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (soreness after first dose (left arm)), VACCINATION SITE WARMTH (Felt a little warm the second day of first dose (left arm)) and ERYTHEMA (days/couple weeks she found a red patch on left arm) in a 72-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013M20A) for COVID-19 vaccination.     Concomitant products included BUDESONIDE (PULMICORT) for Asthma, OLMESARTAN for Blood pressure abnormal, MIRTAZAPINE for Insomnia NOS, ASCORBIC ACID, TOCOPHERYL ACETATE, XANTOFYL, ZEAXANTHIN, ZINC (AREDS) for Macular degeneration, BUPROPION HYDROCHLORIDE (WELLBUTRIN), BIFIDOBACTERIUM LACTIS (PROBIOTIC [BIFIDOBACTERIUM LACTIS]), MONTELUKAST, CALCIUM, OMEGA-3 [OMEGA-3 NOS] and MULTIVITAMINS [VITAMINS NOS] for an unknown indication.    On 26-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 26-Jan-2021, the patient experienced PAIN IN EXTREMITY (soreness after first dose (left arm)). On 27-Jan-2021, the patient experienced VACCINATION SITE WARMTH (Felt a little warm the second day of first dose (left arm)). On an unknown date, the patient experienced ERYTHEMA (days/couple weeks she found a red patch on left arm). At the time of the report, PAIN IN EXTREMITY (soreness after first dose (left arm)), VACCINATION SITE WARMTH (Felt a little warm the second day of first dose (left arm)) and ERYTHEMA (days/couple weeks she found a red patch on left arm) outcome was unknown. Early morning on 24Feb2021(2 extra strength Tylenol) night on 23Feb2021 took (2 extra strength Tylenol) on 23Feb2021 took (2 Extra Strength Tylenol)      mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) dosing remained unchanged.       No treatment medications were reported.
Age: 34.0
Sex: F
Vaccine: COVID19
Symptoms: Decreased appetite, Fatigue, Gait disturbance, Headache, Myalgia
Clinical narrative: lost appetite; sore throat; muscle pain; lot of headache; nausea; fever goes up and down; tiredness; could not get up, could not walk because of muscle pain; just arm pain / pain in her arm; This spontaneous case was reported by a physician and describes the occurrence of GAIT DISTURBANCE (could not get up, could not walk because of muscle pain), DECREASED APPETITE (lost appetite), OROPHARYNGEAL PAIN (sore throat), MYALGIA (muscle pain) and HEADACHE (lot of headache) in a 34-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 011J20A and 030L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history was provided by the reporter. .    On 09-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 09-Jan-2021, the patient experienced VACCINATION SITE PAIN (just arm pain / pain in her arm). On 04-Feb-2021, the patient experienced GAIT DISTURBANCE (could not get up, could not walk because of muscle pain). On an unknown date, the patient experienced DECREASED APPETITE (lost appetite), OROPHARYNGEAL PAIN (sore throat), MYALGIA (muscle pain), HEADACHE (lot of headache), NAUSEA (nausea), PYREXIA (fever goes up and down) and FATIGUE (tiredness). The patient was treated with ACETAMINOPHEN at an unspecified dose and frequency. At the time of the report, GAIT DISTURBANCE (could not get up, could not walk because of muscle pain), DECREASED APPETITE (lost appetite), OROPHARYNGEAL PAIN (sore throat), MYALGIA (muscle pain), HEADACHE (lot of headache), NAUSEA (nausea), PYREXIA (fever goes up and down), FATIGUE (tiredness) and VACCINATION SITE PAIN (just arm pain / pain in her arm) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications were reported.
Age: 34.0
Sex: F
Vaccine: COVID19
Symptoms: Nausea, Oropharyngeal pain, Pyrexia, Vaccination site pain
Clinical narrative: lost appetite; sore throat; muscle pain; lot of headache; nausea; fever goes up and down; tiredness; could not get up, could not walk because of muscle pain; just arm pain / pain in her arm; This spontaneous case was reported by a physician and describes the occurrence of GAIT DISTURBANCE (could not get up, could not walk because of muscle pain), DECREASED APPETITE (lost appetite), OROPHARYNGEAL PAIN (sore throat), MYALGIA (muscle pain) and HEADACHE (lot of headache) in a 34-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 011J20A and 030L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history was provided by the reporter. .    On 09-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 09-Jan-2021, the patient experienced VACCINATION SITE PAIN (just arm pain / pain in her arm). On 04-Feb-2021, the patient experienced GAIT DISTURBANCE (could not get up, could not walk because of muscle pain). On an unknown date, the patient experienced DECREASED APPETITE (lost appetite), OROPHARYNGEAL PAIN (sore throat), MYALGIA (muscle pain), HEADACHE (lot of headache), NAUSEA (nausea), PYREXIA (fever goes up and down) and FATIGUE (tiredness). The patient was treated with ACETAMINOPHEN at an unspecified dose and frequency. At the time of the report, GAIT DISTURBANCE (could not get up, could not walk because of muscle pain), DECREASED APPETITE (lost appetite), OROPHARYNGEAL PAIN (sore throat), MYALGIA (muscle pain), HEADACHE (lot of headache), NAUSEA (nausea), PYREXIA (fever goes up and down), FATIGUE (tiredness) and VACCINATION SITE PAIN (just arm pain / pain in her arm) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications were reported.
Age: 81.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Dry throat, Dyspnoea, Headache, Influenza like illness
Clinical narrative: Flu like symptoms; Cant breath well; Dry throat, need to drink water; Mild fever (99.7F); Runny nose that goes to my throat and bothers; Headache; Arm  hurting; A spontaneous report was received from a consumer concerning a 81-years-old female patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced events mild fever (99.7f)/pyrexia, flu like symptoms/influenza like illness, runny nose that went to throat and bothered /rhinorrhea, couldnt breath well/dyspnea, dry throat needed to drink water/dry throat, headache, arm hurting/pain in extremity.  The patient's medical history was not provided. Concomitant medications reported were fexofenadine hydrochloride, unspecified blood pressure, diabetes medications.  On 19 Jan 2021, the patient received first of two planned doses of mRNA-1273 (lot/batch: 030L20A) in the left arm for prophylaxis of COVID-19 infection. No adverse event reported related to the first dose of vaccine.  On 20 Feb 2021, prior to the onset of the events the patient received their second of two planned doses of mRNA-1273 (lot/batch: 024M20A) in the left arm for prophylaxis of COVID-19 infection.  On an unknown date, the patient experienced the events mild fever (99.7F), flu like symptoms. On 22 Feb 2021, the patient experienced the events headache, arm hurting. On 23 Feb 2021, the patient experienced the events runny nose that went to her throat and bothered, she couldn't breath well, had dry throat, needed to drink water.  Treatment details included Tylenol.  Since patient received both the scheduled doses of vaccine action taken with mRNA-1273 in response to the events was not applicable.  The outcome of events mild fever (99, 7f), flu like symptoms, runny nose that goes to my throat and bothers, cant breath well, dry throat, need to drink water, headache, arm hurting was unknown.
Age: 81.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia, Rhinorrhoea, Vaccination site pain
Clinical narrative: Flu like symptoms; Cant breath well; Dry throat, need to drink water; Mild fever (99.7F); Runny nose that goes to my throat and bothers; Headache; Arm  hurting; A spontaneous report was received from a consumer concerning a 81-years-old female patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced events mild fever (99.7f)/pyrexia, flu like symptoms/influenza like illness, runny nose that went to throat and bothered /rhinorrhea, couldnt breath well/dyspnea, dry throat needed to drink water/dry throat, headache, arm hurting/pain in extremity.  The patient's medical history was not provided. Concomitant medications reported were fexofenadine hydrochloride, unspecified blood pressure, diabetes medications.  On 19 Jan 2021, the patient received first of two planned doses of mRNA-1273 (lot/batch: 030L20A) in the left arm for prophylaxis of COVID-19 infection. No adverse event reported related to the first dose of vaccine.  On 20 Feb 2021, prior to the onset of the events the patient received their second of two planned doses of mRNA-1273 (lot/batch: 024M20A) in the left arm for prophylaxis of COVID-19 infection.  On an unknown date, the patient experienced the events mild fever (99.7F), flu like symptoms. On 22 Feb 2021, the patient experienced the events headache, arm hurting. On 23 Feb 2021, the patient experienced the events runny nose that went to her throat and bothered, she couldn't breath well, had dry throat, needed to drink water.  Treatment details included Tylenol.  Since patient received both the scheduled doses of vaccine action taken with mRNA-1273 in response to the events was not applicable.  The outcome of events mild fever (99, 7f), flu like symptoms, runny nose that goes to my throat and bothers, cant breath well, dry throat, need to drink water, headache, arm hurting was unknown.
Age: 82.0
Sex: F
Vaccine: COVID19
Symptoms: Device connection issue, Underdose
Clinical narrative: She thinks some vaccine leaked on her/ Liquid run down my arm; She thinks some vaccine leaked on her; This spontaneous case was reported by a consumer and describes the occurrence of UNDERDOSE (She thinks some vaccine leaked on her/ Liquid run down my arm) and DEVICE CONNECTION ISSUE (She thinks some vaccine leaked on her) in an 82-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 001A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 23-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 23-Feb-2021, the patient experienced UNDERDOSE (She thinks some vaccine leaked on her/ Liquid run down my arm) and DEVICE CONNECTION ISSUE (She thinks some vaccine leaked on her). On 23-Feb-2021, UNDERDOSE (She thinks some vaccine leaked on her/ Liquid run down my arm) and DEVICE CONNECTION ISSUE (She thinks some vaccine leaked on her) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant and treatment medications were reported.   Most recent FOLLOW-UP information incorporated above includes: On 19-Jul-2021: Significant follow up appended, Same reporter with new address and height, weight added and patient enthinic group and race provided
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site bruising, Vaccination site swelling
Clinical narrative: BRUISING AT THE INJECTION SITE; SWOLLEN ARM AT INJECTION SITE; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE SWELLING (SWOLLEN ARM AT INJECTION SITE) and VACCINATION SITE BRUISING (BRUISING AT THE INJECTION SITE) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 22-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE SWELLING (SWOLLEN ARM AT INJECTION SITE) and VACCINATION SITE BRUISING (BRUISING AT THE INJECTION SITE). At the time of the report, VACCINATION SITE SWELLING (SWOLLEN ARM AT INJECTION SITE) and VACCINATION SITE BRUISING (BRUISING AT THE INJECTION SITE) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant medication were not reported. treatment information was not provided.
Age: 40.0
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Body temperature, Chills, Fatigue, Headache
Clinical narrative: Muscle pain; headache she couldn't move; aches; sick; chills; very tired, she cant do anything; sweat; body aches; fever; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (body aches), PAIN IN EXTREMITY (aches), HYPERHIDROSIS (sweat), ASTHENIA (sick) and FATIGUE (very tired, she cant do anything) in a 40-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 029L20A and 024M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Thyroid disorder.   On 22-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 19-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 20-Feb-2021, the patient experienced PAIN (body aches), HYPERHIDROSIS (sweat), FATIGUE (very tired, she cant do anything) and PYREXIA (fever). On 23-Feb-2021, the patient experienced PAIN IN EXTREMITY (aches), ASTHENIA (sick), HEADACHE (headache she couldn't move) and CHILLS (chills). On 24-Feb-2021, the patient experienced MYALGIA (Muscle pain). The patient was treated with IBUPROFEN at an unspecified dose and frequency and PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, PAIN (body aches), PAIN IN EXTREMITY (aches), HYPERHIDROSIS (sweat), ASTHENIA (sick), FATIGUE (very tired, she cant do anything), HEADACHE (headache she couldn't move), MYALGIA (Muscle pain), PYREXIA (fever) and CHILLS (chills) outcome was unknown. Not Provided    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Body temperature: 101.8 (High) 101.8°F.         Concomitant medication included Thyroids pills, slow dose, The patient reported that she had pretty good immune system.
Age: 40.0
Sex: F
Vaccine: COVID19
Symptoms: Hyperhidrosis, Myalgia, Pain, Pain in extremity, Pyrexia
Clinical narrative: Muscle pain; headache she couldn't move; aches; sick; chills; very tired, she cant do anything; sweat; body aches; fever; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (body aches), PAIN IN EXTREMITY (aches), HYPERHIDROSIS (sweat), ASTHENIA (sick) and FATIGUE (very tired, she cant do anything) in a 40-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 029L20A and 024M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Thyroid disorder.   On 22-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 19-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 20-Feb-2021, the patient experienced PAIN (body aches), HYPERHIDROSIS (sweat), FATIGUE (very tired, she cant do anything) and PYREXIA (fever). On 23-Feb-2021, the patient experienced PAIN IN EXTREMITY (aches), ASTHENIA (sick), HEADACHE (headache she couldn't move) and CHILLS (chills). On 24-Feb-2021, the patient experienced MYALGIA (Muscle pain). The patient was treated with IBUPROFEN at an unspecified dose and frequency and PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, PAIN (body aches), PAIN IN EXTREMITY (aches), HYPERHIDROSIS (sweat), ASTHENIA (sick), FATIGUE (very tired, she cant do anything), HEADACHE (headache she couldn't move), MYALGIA (Muscle pain), PYREXIA (fever) and CHILLS (chills) outcome was unknown. Not Provided    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Body temperature: 101.8 (High) 101.8°F.         Concomitant medication included Thyroids pills, slow dose, The patient reported that she had pretty good immune system.
Age: 73.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Dizziness, Vaccination site swelling
Clinical narrative: very dizziness; arm is swollen up (L arm, injection site); chills like a flu; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (very dizziness), VACCINATION SITE SWELLING (arm is swollen up (L arm, injection site)) and CHILLS (chills like a flu) in a 73-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 001A21A) for COVID-19 vaccination.     Concurrent medical conditions included Diabetes mellitus.    On 23-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced DIZZINESS (very dizziness), VACCINATION SITE SWELLING (arm is swollen up (L arm, injection site)) and CHILLS (chills like a flu). At the time of the report, DIZZINESS (very dizziness), VACCINATION SITE SWELLING (arm is swollen up (L arm, injection site)) and CHILLS (chills like a flu) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitantly, patient was taking medication for diabetes type 2. No treatment related information has been reported.   Reporter did not allow further contact
Age: 78.0
Sex: M
Vaccine: COVID19
Symptoms: Dry eye, Ocular discomfort
Clinical narrative: Diagnosed with "dry eyes" by Optometrist; Felt "Something in left eye and right eye; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of OCULAR DISCOMFORT (Felt "Something in left eye and right eye) and DRY EYE (Diagnosed with "dry eyes" by Optometrist) in a 78-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Hypertension.    On 11-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 12-Feb-2021, the patient experienced OCULAR DISCOMFORT (Felt "Something in left eye and right eye). On 16-Feb-2021, the patient experienced DRY EYE (Diagnosed with "dry eyes" by Optometrist). At the time of the report, OCULAR DISCOMFORT (Felt "Something in left eye and right eye) and DRY EYE (Diagnosed with "dry eyes" by Optometrist) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant medications included medications for high blood pressure.  Treatment medication included no tears eye drops.
Age: 79.0
Sex: M
Vaccine: COVID19
Symptoms: Pruritus, Rash
Clinical narrative: Itchiness; Rash; This spontaneous case was reported by a consumer and describes the occurrence of PRURITUS (Itchiness) and RASH (Rash) in a 79-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 041L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 22-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 04-Feb-2021, the patient experienced PRURITUS (Itchiness) and RASH (Rash). At the time of the report, PRURITUS (Itchiness) and RASH (Rash) had not resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications reported by investigator o No treatment medications provided by the reporter.
Age: 74.0
Sex: M
Vaccine: COVID19
Symptoms: Arthralgia, Discomfort, Tremor
Clinical narrative: Has periods of tremulousness in same injection site arm; shoulder is aching this morning at the injection site; uncomfortable overnight period; This spontaneous case was reported by an other health care professional and describes the occurrence of DISCOMFORT (uncomfortable overnight period), TREMOR (Has periods of tremulousness in same injection site arm) and ARTHRALGIA (shoulder is aching this morning at the injection site) in a 74-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030M20A) for COVID-19 vaccination.     No Medical History information was reported.   On 23-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 23-Feb-2021, the patient experienced DISCOMFORT (uncomfortable overnight period). On 24-Feb-2021, the patient experienced TREMOR (Has periods of tremulousness in same injection site arm) and ARTHRALGIA (shoulder is aching this morning at the injection site). At the time of the report, DISCOMFORT (uncomfortable overnight period), TREMOR (Has periods of tremulousness in same injection site arm) and ARTHRALGIA (shoulder is aching this morning at the injection site) had not resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications reported by investigator o No treatment medications provided by the reporter.
Age: 42.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Diarrhoea, Eructation, Pain in extremity, Pyrexia
Clinical narrative: Extremely watery bowel movements; Very unpleasant smell when belches; Arm pain; Fever; Chills; This spontaneous case was reported by a consumer and describes the occurrence of DIARRHOEA (Extremely watery bowel movements), ERUCTATION (Very unpleasant smell when belches), PAIN IN EXTREMITY (Arm pain), PYREXIA (Fever) and CHILLS (Chills) in a 42-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 042L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 19-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 19-Jan-2021, the patient experienced PAIN IN EXTREMITY (Arm pain), PYREXIA (Fever) and CHILLS (Chills). On 20-Jan-2021, the patient experienced DIARRHOEA (Extremely watery bowel movements) and ERUCTATION (Very unpleasant smell when belches). The patient was treated with BISMUTH SUBSALICYLATE (PEPTO-BISMOL) ongoing since an unknown date at an unspecified dose and frequency. On 20-Jan-2021, PYREXIA (Fever) had resolved. On 21-Jan-2021, PAIN IN EXTREMITY (Arm pain) had resolved. At the time of the report, DIARRHOEA (Extremely watery bowel movements) was resolving and ERUCTATION (Very unpleasant smell when belches) and CHILLS (Chills) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       The concomitant medications were not provided.
Age: 64.0
Sex: F
Vaccine: COVID19
Symptoms: Diarrhoea, Headache, Pain, Vomiting
Clinical narrative: Sore arm; Diarrhea; Headache; Vomiting; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (Sore arm), DIARRHOEA (Diarrhea), HEADACHE (Headache) and VOMITING (Vomiting) in a 64-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 022m20a) for COVID-19 vaccination.     No Medical History information was reported.    On 24-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. In February 2021, the patient experienced PAIN (Sore arm), DIARRHOEA (Diarrhea), HEADACHE (Headache) and VOMITING (Vomiting). At the time of the report, PAIN (Sore arm), DIARRHOEA (Diarrhea), HEADACHE (Headache) and VOMITING (Vomiting) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications reported by investigator o No treatment medications provided by the reporter.
Age: 88.0
Sex: F
Vaccine: COVID19
Symptoms: Balance disorder, Headache, Myalgia, Vaccination site pain
Clinical narrative: Headache in right side of eye; Didn't fall completely but I tripped over; Body aches; Sore arm; This spontaneous case was reported by a consumer and describes the occurrence of BALANCE DISORDER (Didn't fall completely but I tripped over), MYALGIA (Body aches), VACCINATION SITE PAIN (Sore arm) and HEADACHE (Headache in right side of eye) in an 88-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Glaucoma. Concomitant products included TRAVOPROST (TRAVATAN Z), APIXABAN (ELIQUIS), METOPROLOL SUCCINATE (TOPROL XL), AMLODIPINE BESILATE (NORVASC) and ALBUTEROL [SALBUTAMOL] for an unknown indication.   On 22-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 23-Feb-2021, the patient experienced BALANCE DISORDER (Didn't fall completely but I tripped over), MYALGIA (Body aches) and VACCINATION SITE PAIN (Sore arm). On an unknown date, the patient experienced HEADACHE (Headache in right side of eye). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, BALANCE DISORDER (Didn't fall completely but I tripped over), MYALGIA (Body aches), VACCINATION SITE PAIN (Sore arm) and HEADACHE (Headache in right side of eye) outcome was unknown.            Other treatment information included cold pack and heat pack.  Action taken with mRNA-1273 in response to the events was not applicable.  Company comment: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
Sex: F
Vaccine: COVID19
Symptoms: Exposure during pregnancy
Clinical narrative: pregnant; This spontaneous retrospective pregnancy case was reported by a consumer and describes the occurrence of EXPOSURE DURING PREGNANCY (pregnant) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. Last menstrual period and estimated date of delivery were not provided. On an unknown date, the patient experienced EXPOSURE DURING PREGNANCY (pregnant). At the time of the report, EXPOSURE DURING PREGNANCY (pregnant) outcome was unknown.            No concomitant medications reported by investigator o No treatment medications provided by the reporter.
Sex: F
Vaccine: COVID19
Symptoms: Hypersensitivity, Vaccination site erythema, Vaccination site pruritus
Clinical narrative: Allergic reaction; Itch 3 inches long and 2 inches wide; Redness and an itch 3 inches long and 2 inches wide; This spontaneous case was reported by a consumer and describes the occurrence of HYPERSENSITIVITY (Allergic reaction), VACCINATION SITE PRURITUS (Itch 3 inches long and 2 inches wide) and VACCINATION SITE ERYTHEMA (Redness and an itch 3 inches long and 2 inches wide) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced HYPERSENSITIVITY (Allergic reaction), VACCINATION SITE PRURITUS (Itch 3 inches long and 2 inches wide) and VACCINATION SITE ERYTHEMA (Redness and an itch 3 inches long and 2 inches wide). At the time of the report, HYPERSENSITIVITY (Allergic reaction), VACCINATION SITE PRURITUS (Itch 3 inches long and 2 inches wide) and VACCINATION SITE ERYTHEMA (Redness and an itch 3 inches long and 2 inches wide) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications were not provided.  Treatment medication was not provided.